IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,511,542 | +2.0% | 424,017 | +0.8% | 0.42% | +9.5% |
| Q1 2023 | $4,424,891 | -15.1% | 420,617 | 0.0% | 0.38% | -13.9% |
| Q4 2022 | $5,211,445 | +20.1% | 420,617 | +0.4% | 0.44% | +12.2% |
| Q3 2022 | $4,340,000 | +12.5% | 418,917 | +25.2% | 0.39% | +26.9% |
| Q2 2022 | $3,857,000 | -8.9% | 334,517 | -0.6% | 0.31% | +12.8% |
| Q1 2022 | $4,234,000 | +6.9% | 336,517 | -0.9% | 0.27% | +3.4% |
| Q4 2021 | $3,961,000 | -11.0% | 339,617 | -0.3% | 0.26% | -22.7% |
| Q3 2021 | $4,449,000 | +14.2% | 340,617 | +12.6% | 0.34% | +10.6% |
| Q2 2021 | $3,895,000 | +15.1% | 302,617 | 0.0% | 0.31% | +9.5% |
| Q1 2021 | $3,383,000 | +7254.3% | 302,617 | +6478.6% | 0.28% | +1786.7% |
| Q2 2013 | $46,000 | – | 4,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |